Growth Metrics

Standard Biotools (LAB) Convertible Debt (2016 - 2025)

Historic Convertible Debt for Standard Biotools (LAB) over the last 12 years, with Q3 2025 value amounting to $299000.0.

  • Standard Biotools' Convertible Debt changed 0.0% to $299000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $299000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $299000.0 for FY2024, which is 4745.17% down from last year.
  • Latest data reveals that Standard Biotools reported Convertible Debt of $299000.0 as of Q3 2025, which was down 0.0% from $299000.0 recorded in Q2 2025.
  • Standard Biotools' Convertible Debt's 5-year high stood at $55.0 million during Q3 2023, with a 5-year trough of $299000.0 in Q1 2024.
  • Moreover, its 5-year median value for Convertible Debt was $53.9 million (2021), whereas its average is $31.6 million.
  • Its Convertible Debt has fluctuated over the past 5 years, first skyrocketed by 87.34% in 2023, then plummeted by 9945.61% in 2024.
  • Quarter analysis of 5 years shows Standard Biotools' Convertible Debt stood at $54.2 million in 2021, then increased by 0.84% to $54.6 million in 2022, then crashed by 98.96% to $569000.0 in 2023, then tumbled by 47.45% to $299000.0 in 2024, then changed by 0.0% to $299000.0 in 2025.
  • Its Convertible Debt was $299000.0 in Q3 2025, compared to $299000.0 in Q2 2025 and $299000.0 in Q1 2025.